EFTA02657725

From: Sent: To: Subject: ok On Fri, Mar 3, 2017 at 5:32 PM, < Mail to both. F jeffrey E. <[email protected]> M Re: bgc3 Deliverables and Scope -ri:inal Messa:e To: mwalkermd <[email protected] <mailto:[email protected]» Sent: Fri, Mar 3, 2017 5:31 pm Subject: FW: bgc3 Deliverables and Scope Fro Sent: Friday, March 3, 2017 5:31 PM To: 'Bill Gates' <[email protected] <mailto:[email protected]» Cc: Larry Cohen <[email protected] <mailto:[email protected]» Subject: bgc3 Deliverables and Scope Bill — Larry and I have been=working on deliverables for my time at bgc3 since you and I spoke. At Larr='s request I have spoken with Rodger, Mark, Chris, Trevor, Geoff =E24 and next week Bose/Jonah. Everyone has offered guidance, advice t=oughts and ideas. As Larry works to put=together any required documentation, we are trying to make sure we make th=s time valuable for all. Two areas where I am =nterested, in terms of scope: domestic health and neurotech/brain science.=/div> I propose these as de=iverables, please let Larry and I know what you think. Deliverables:<=div> 1. To improve access and secure personal health data (affordabil=ty/access) -->Blueprint and/or recomme=dations for a zero knowledge proof-based digital system to secure private personal=health information while allowing access to digitally redacted personal in=ormation 2. Whitepaper on consumer health expenditures in the USA 3. Whitepaper and/or recommendations on neurotechnologies relate= to chronic/degenerative disease 4. Whitepaper on Neurotechnologies as weapons in national intell=gence and defense 5. Follow-up recommendations and/or technical specifications for Strain pandemic simulation EFTA_R1_01904025 EFTA02657725 Happy to do whatever =Ise is helpful — or adapt along the way. Thanks for the opport=nity...hope the weekend is off to a good start. Melanie =C24> please note The information co=tained in this communication is confidential, may be attorney-client pr=vileged, may constitute inside information, and is intended only for JEE Unauthorized use= disclosure or copying of this communication or any part thereof is str=ctly prohibited and may be unlawful. If you have received this commu=ication in error, please notify us immediately by return e-mail or by e=mail to [email protected] <mailto:[email protected]> , and destroy this communication and all copies thereo=, including all attachments. copyright -all rights reserved </=iv> 2 EFTA_R1_01904026 EFTA02657726